Molecular sources of residual cardiovascular risk, clinical signals, and innovative solutions: relationship with subclinical disease, undertreatment, and poor adherence: implications of new evidence upon optimizing cardiovascular patient outcomes (Q37254899)

From Wikidata
Jump to navigation Jump to search
scientific article published on 21 October 2013
edit
Language Label Description Also known as
English
Molecular sources of residual cardiovascular risk, clinical signals, and innovative solutions: relationship with subclinical disease, undertreatment, and poor adherence: implications of new evidence upon optimizing cardiovascular patient outcomes
scientific article published on 21 October 2013

    Statements

    Molecular sources of residual cardiovascular risk, clinical signals, and innovative solutions: relationship with subclinical disease, undertreatment, and poor adherence: implications of new evidence upon optimizing cardiovascular patient outcomes (English)
    1 reference
    19 November 2019
    1 reference
    8 August 2019
    2 references
    2 October 2019
    28 January 2021
    1 reference
    19 November 2019
    1 reference
    19 January 2021
    617-670

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit